Package 62135-466-30

Brand: tenofovir disoproxil fumarate

Generic: tenofovir disoproxil fumarate tablets
NDC Package

Package Facts

Identity

Package NDC 62135-466-30
Digits Only 6213546630
Product NDC 62135-466
Description

30 TABLET, FILM COATED in 1 BOTTLE (62135-466-30)

Marketing

Marketing Status
Marketed Since 2022-06-30
Brand tenofovir disoproxil fumarate
Generic tenofovir disoproxil fumarate tablets
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ef9f6879-525d-e5a6-e053-2a95a90ad8be", "openfda": {"upc": ["0362135466305"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["9cf11bd3-01b9-4ac8-96cc-55d57998b51d"], "manufacturer_name": ["Chartwell RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (62135-466-30)", "package_ndc": "62135-466-30", "marketing_start_date": "20220630"}], "brand_name": "TENOFOVIR DISOPROXIL FUMARATE", "product_id": "62135-466_ef9f6879-525d-e5a6-e053-2a95a90ad8be", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "62135-466", "generic_name": "TENOFOVIR DISOPROXIL FUMARATE Tablets", "labeler_name": "Chartwell RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TENOFOVIR DISOPROXIL FUMARATE", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA206481", "marketing_category": "ANDA", "marketing_start_date": "20180731", "listing_expiration_date": "20261231"}